After-Hours Stock Movers 05/23: Snap's Warning Sends Shivers Throughout Tech; Zoom Gains on Results (more...)
- Growth stocks drag Nasdaq lower, energy shares bounce
- Just Another Bear Market Rally, Morgan Stanley's Wilson Says
- Oil prices rise amid G7 talks on new Russian sanctions
- Coinbase Downgraded to Sell at Goldman on Further Downside Risk, Robinhood Upgraded to Neutral on Better Risk-Reward
- Michael Burry Warns of the Bullwhip Effect, Says the Fed Could Reverse Course
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
After-Hours Stock Movers:
Snap (NYSE: SNAP) 28% LOWER; warns for Q2. The company said since they issued guidance on April 21, 2022, the macroeconomic environment has deteriorated further and faster than anticipated. As a result, we believe it is likely that we will report revenue and adjusted EBITDA below the low end of our Q2 2022 guidance range.
INmune Bio, Inc. (NASDAQ: INMB) 20% LOWER; announced that on May 20, 2022, the Company was informed via e-mail communication from the U.S. Food and Drug Administration (FDA) requesting additional information around Chemistry Manufacturing and Controls (CMC) of the newly manufactured XPro1595 (XPro™). As part of the communication, the Agency placed the Company’s Investigational New Drug (IND) application to initiate its Phase 2 clinical trial of XPro™ in patients with Alzheimer’s Disease (AD) in the U.S. on clinical hold. The FDA indicated they will provide an official clinical hold letter to INmune in approximately 30 days. INmune plans to provide additional updates pending discussion with the FDA. The Phase 2 trial of XPro™ remains open in Australia and continues to enroll patients.
Nautilus (NYSE: NLS) 14% LOWER; reported Q4 EPS of ($0.58), in-line with the analyst estimate of ($0.58). Revenue for the quarter came in at $119.7 million versus the consensus estimate of $120.85 million.
Pinterest, Inc. (NYSE: PINS) 12% LOWER; falls on Snap's Q2 warning.
Meta Platforms, Inc. (NASDAQ: FB) 8% LOWER; falls on Snap's Q2 warning.
Zoom (NASDAQ: ZM) 5% HIGHER; reported Q1 EPS of $1.03, $0.16 better than the analyst estimate of $0.87. Revenue for the quarter came in at $1.07 billion versus the consensus estimate of $1.07 billion. Zoom sees Q2 2023 EPS of $0.90-$0.92, versus the consensus of $0.88. Zoom sees Q2 2023 revenue of $1.115-1.12 billion, versus the consensus of $1.11 billion. Zoom sees FY2023 EPS of $3.70-$3.77, versus the consensus of $3.53. Zoom sees FY2023 revenue of $4.53-4.55 billion, versus the consensus of $4.55 billion.
Google (NASDAQ: GOOGL) 4% LOWER; falls on Snap's Q2 warning.
Twitter, Inc. (NASDAQ: TWTR) 4% LOWER; falls on Snap's Q2 warning.
Albemarle Corporation (NYSE: ALB) 3% HIGHER; further revised its full-year 2022 guidance today, reflecting mainly the completion of additional lithium contract renegotiations with its lithium customers following its Q1/22 earnings release on May 4, 2022. Net sales are now expected to be in the range of $5.8 - $6.2 billion versus the prior outlook of $5.2 - $5.6 billion and the consensus of $5.44 billion. Adjusted EBITDA is now seen in the range of $2.2 - $2.5 billion versus the prior guidance of $1.7 - $2.0 billion. Adjusted diluted EPS in the range of $12.30 - $15.00 versus the consensus of $10.88 and prior guidance of $9.25 - $12.25.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BioNTech SE (BNTX) and Pfizer (PFE) Report Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against
- ProMIS Neurosciences (ARFXF) Announces 1:60 Reverse Share Split to Meet Nasdaq Requirements
- Staffing 360 Solutions (STAF) Reports FY21 Revenue of $197.8M, Net Income of $8.2M
Create E-mail Alert Related CategoriesSpecial Reports
Related EntitiesTwitter, After-Hours Movers, Earnings, FDA
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!